iCo Therapeutics Begins Trading on the OTCQX Marketplace
December 20, 2013, Vancouver, Canadaâ€"iCo Therapeutics (TSX-V: ICO) (OTCQX: ICOTF), announced that its common
December 20, 2013, Vancouver, Canadaâ€"iCo Therapeutics (TSX-V: ICO) (OTCQX: ICOTF), announced that its common
December 12, 2013, Vancouver, Canada — iCo Therapeutics (TSX-V: ICO), today announced that on
December 5, 2013, Vancouver, Canada — iCo Therapeutics (TSX-V: ICO), today announced that Management
November 27, 2013, Vancouver, Canada—iCo Therapeutics (TSX-V: ICO), today reported financial results for the
November 21, 2013, Vancouver, Canada— iCo Therapeutics Inc. (TSX-V: ICO), today announced that Management
November 13, 2013, Vancouver, Canada—iCo Therapeutics Inc. (TSX-V: ICO), today announced that subsequent to
November 7, 2013, Vancouver, Canada—iCo Therapeutics Inc. (TSX-V: ICO), today announced that Management will
September 5, 2013, Vancouver, Canada — iCo Therapeutics Inc. (“iCo” or “the Company”) (TSX-V:
September 4, 2013, Vancouver, Canada—iCo Therapeutics Inc. (TSX-V: ICO), today announced it will be
August 26, 2013, Vancouver, Canada—iCo Therapeutics (TSX-V: ICO), today reported financial results for the